This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kenneth P. Miller, MD; Eliot J. Lazar, MD; Serban Fotino, MD

Arch Intern Med. 1984;144(12):2414-2415.

Abstract
• Severe hyperkalemia developed In an 85-year-old man after he had been receiving piroxicam treatment for several months. At admission his serum potassium level was 9.3 mEq/L; total Co2 level, 11 mmole/L; chloride level, 122 mEq/L; serum urea nitrogen level, 54 mg/dL; and creatininine level, 2.5 mg/dL. Hyperkalemia resolved after withdrawal of the drug and polystyrene sodium sulfonate therapy and the nonanlon gap acidosis subsided concomitantly. His serum urea nitrogen and creatinine levels remained unchanged. He had abnormally low plasma renin activity, which gradually returned to normal, and aldosterone concentration, which remained low. The nonsteroldal drug may have impaired renln secretion, adrenal responsiveness to angiotensin, or the action of aldosterone on the renal tubule.

(Arch Intern Med 1984;144:2414-2415)

Author Affiliations
From the Department of Medicine, Albert Einstein College of Medicine, Bronx (NY) Municipal Hospital Center.

Footnotes
Accepted for publication Feb 29, 1984.

Reprint requests to Bronx Municipal Hospital Center, Pelham Parkway and Eastchester Road, Bronx, NY 10461 (Dr Fotino).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyperkalemia as a Complication of Drug Therapy
Rimmer et al.
Arch Intern Med 1987;147:867-869.
ABSTRACT